Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalion's AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.

Biotechnology

Kedalion Therapeutics

Mark Blumenkranz

Mark Murray

Ehud Ivri

Casey Dougan

Joseph Gilbert

Reynaldo Quintana

The executive team at Kedalion Therapeutics has a history of working in various industries, including healthcare, consulting, and technology. They have also received education from some of the top schools in the world, including the Wharton School, Brown University, and the Technion - Israel Institute of Technology.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Kedalion Therapeutics

Board of Directors

Leadership Team